Should a new Alzheimer’s drug have been approved by the FDA? Elizabeth Tracey reports
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Aduhelm is the proprietary name for aducanumab, a just approved medication for treatment of Alzheimer’s disease. Caleb Alexander, an internal medicine expert at Johns Hopkins, sat on the FDA review board for this medicine and explains why he voted no …
Should a new Alzheimer’s drug have been approved by the FDA? Elizabeth Tracey reports Read more »